149 related articles for article (PubMed ID: 8356908)
1. Role of glutathione in cellular resistance to alkylating agents.
Colvin OM; Friedman HS; Gamcsik MP; Fenselau C; Hilton J
Adv Enzyme Regul; 1993; 33():19-26. PubMed ID: 8356908
[TBL] [Abstract][Full Text] [Related]
2. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione.
Dirven HA; van Ommen B; van Bladeren PJ
Cancer Res; 1994 Dec; 54(23):6215-20. PubMed ID: 7954469
[TBL] [Abstract][Full Text] [Related]
3. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
[TBL] [Abstract][Full Text] [Related]
4. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
Yuan ZM; Smith PB; Brundrett RB; Colvin M; Fenselau C
Drug Metab Dispos; 1991; 19(3):625-9. PubMed ID: 1680629
[TBL] [Abstract][Full Text] [Related]
5. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity.
Alaoui-Jamali MA; Panasci L; Centurioni GM; Schecter R; Lehnert S; Batist G
Cancer Chemother Pharmacol; 1992; 30(5):341-7. PubMed ID: 1505071
[TBL] [Abstract][Full Text] [Related]
6. A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro.
McGown AT; Fox BW
Cancer Chemother Pharmacol; 1986; 17(3):223-6. PubMed ID: 3742706
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells.
Ripple M; Mulcahy RT; Wilding G
J Urol; 1993 Jul; 150(1):209-14. PubMed ID: 8510259
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic mechanisms of resistance to alkylating agents in tumor cells and normal tissues.
Colvin M; Russo JE; Hilton J; Dulik DM; Fenselau C
Adv Enzyme Regul; 1988; 27():211-21. PubMed ID: 3074628
[TBL] [Abstract][Full Text] [Related]
9. Glutathione conjugation of the cytostatic drug ifosfamide and the role of human glutathione S-transferases.
Dirven HA; Megens L; Oudshoorn MJ; Dingemanse MA; van Ommen B; van Bladeren PJ
Chem Res Toxicol; 1995; 8(7):979-86. PubMed ID: 8555414
[TBL] [Abstract][Full Text] [Related]
10. Role of multidrug resistance protein 1 (MRP1) and glutathione S-transferase A1-1 in alkylating agent resistance. Kinetics of glutathione conjugate formation and efflux govern differential cellular sensitivity to chlorambucil versus melphalan toxicity.
Paumi CM; Ledford BG; Smitherman PK; Townsend AJ; Morrow CS
J Biol Chem; 2001 Mar; 276(11):7952-6. PubMed ID: 11115505
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell heterogeneity: impact on mechanisms of therapeutic drug resistance.
Richardson ME; Siemann DW
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):789-95. PubMed ID: 9369124
[TBL] [Abstract][Full Text] [Related]
12. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells.
Chen G; Waxman DJ
Biochem Pharmacol; 1994 Mar; 47(6):1079-87. PubMed ID: 8147907
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of melphalan by rat liver microsomal glutathione S-transferase.
Zhang J; Ye Z; Lou Y
Chem Biol Interact; 2005 Apr; 152(2-3):101-6. PubMed ID: 15840383
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
Nath K; Nelson DS; Putt ME; Leeper DB; Garman B; Nathanson KL; Glickson JD
PLoS One; 2016; 11(6):e0157125. PubMed ID: 27285585
[TBL] [Abstract][Full Text] [Related]
15. Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers.
Ford JM; Hait WN; Matlin SA; Benz CC
Cancer Lett; 1991 Jan; 56(1):85-94. PubMed ID: 2004358
[TBL] [Abstract][Full Text] [Related]
16. Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in clonogenic mouse hematopoietic progenitor cells.
Letourneau S; Greenbaum M; Cournoyer D
Hum Gene Ther; 1996 May; 7(7):831-40. PubMed ID: 8860835
[TBL] [Abstract][Full Text] [Related]
17. In-transit melanoma: the role of alkylating-agent resistance in regional therapy.
Grubbs EG; Abdel-Wahab O; Cheng TY; Abdel-Wahab Z; Peterson B; Pruitt SK; Colvin OM; Friedman HS; Tyler DS
J Am Coll Surg; 2004 Sep; 199(3):419-27. PubMed ID: 15325612
[TBL] [Abstract][Full Text] [Related]
18. Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents.
Britten RA; Green JA; Warenius HM
Int J Radiat Oncol Biol Phys; 1992; 24(3):527-31. PubMed ID: 1399740
[TBL] [Abstract][Full Text] [Related]
19. Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents.
Townsend AJ; Tu CP; Cowan KH
Mol Pharmacol; 1992 Feb; 41(2):230-6. PubMed ID: 1538704
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferases in nitrogen mustard-resistant and -sensitive cell lines.
Buller AL; Clapper ML; Tew KD
Mol Pharmacol; 1987 Jun; 31(6):575-8. PubMed ID: 3600602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
